Corynebacterium striatum: Difference between revisions
From IDWiki
Corynebacterium striatum
(Created page with "{{DISPLAYTITLE:''Corynebacterium striatum''}} == Management == * Only reliably susceptible to vancomycin, daptomycin, and linezolid (essentially 100% susceptibil...") |
mNo edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE:''Corynebacterium striatum''}} |
{{DISPLAYTITLE:''Corynebacterium striatum''}} |
||
== |
==Management== |
||
* |
*Only reliably susceptible to [[vancomycin]], [[daptomycin]], and [[linezolid]] (essentially 100% susceptibility)[[CiteRef::neemuchwala2018in]] |
||
** |
**Next-best oral option is [[tetracycline]], but only has 35% susceptibility, or [[co-trimoxazole]] (similar susceptibility) |
||
** |
**Other options include [[quinupristin-dalfopristin]] (100%), [[aminoglycosides]] (93%), and [[rifampin]] (85%) |
||
[[Category:Gram-positive bacilli]] |
[[Category:Gram-positive bacilli]] |
||
[[Category:Anaerobes]] |
|||
Latest revision as of 15:56, 9 September 2022
Management
- Only reliably susceptible to vancomycin, daptomycin, and linezolid (essentially 100% susceptibility)1
- Next-best oral option is tetracycline, but only has 35% susceptibility, or co-trimoxazole (similar susceptibility)
- Other options include quinupristin-dalfopristin (100%), aminoglycosides (93%), and rifampin (85%)
References
- ^ neemuchwala2018in
